Rhumbline Advisers Chimerix Inc Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Chimerix Inc stock. As of the latest transaction made, Rhumbline Advisers holds 3,730 shares of CMRX stock, worth $3,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,730

Previous 5,391 30.81%

Holding current value

$3,431

Previous $5,000 40.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$0.87 - $1.05 $1,445 - $1,744	-1,661 Reduced 30.81%	3,730 $3,000
Q3 2023 Nov 09, 2023	SELL	$0.94 - $1.23 $5,399 - $7,065	-5,744 Reduced 51.59%	5,391 $5,000
Q2 2023 Aug 08, 2023	SELL	$1.1 - $1.54 $115,533 - $161,746	-105,030 Reduced 90.41%	11,135 $13,000
Q1 2023 May 11, 2023	SELL	$1.19 - $2.09 $10,720 - $18,828	-9,009 Reduced 7.2%	116,165 $146,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $4,238 - $5,964	2,538 Added 2.07%	125,174 $233,000
Q3 2022 Nov 10, 2022	BUY	$1.81 - $2.76 $25,159 - $38,364	13,900 Added 12.78%	122,636 $237,000
Q2 2022 Aug 11, 2022	BUY	$1.34 - $5.34 $12,361 - $49,261	9,225 Added 9.27%	108,736 $226,000
Q1 2022 May 12, 2022	BUY	$4.58 - $6.8 $261 - $387	57 Added 0.06%	99,511 $456,000
Q4 2021 Feb 10, 2022	BUY	$5.23 - $7.18 $4,837 - $6,641	925 Added 0.94%	99,454 $639,000
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $34,410 - $50,688	5,793 Added 6.25%	98,529 $610,000
Q2 2021 Aug 05, 2021	SELL	$7.54 - $9.79 $54,665 - $70,977	-7,250 Reduced 7.25%	92,736 $742,000
Q1 2021 May 06, 2021	BUY	$4.76 - $11.25 $12,495 - $29,531	2,625 Added 2.7%	99,986 $964,000
Q4 2020 Feb 10, 2021	BUY	$2.43 - $5.42 $25,237 - $56,292	10,386 Added 11.94%	97,361 $470,000
Q3 2020 Nov 12, 2020	SELL	$2.3 - $3.72 $23,646 - $38,245	-10,281 Reduced 10.57%	86,975 $217,000
Q2 2020 Aug 13, 2020	BUY	$1.33 - $3.63 $26,361 - $71,950	19,821 Added 25.6%	97,256 $301,000
Q4 2019 Feb 05, 2020	SELL	$1.3 - $2.72 $12,912 - $27,017	-9,933 Reduced 11.37%	77,435 $157,000
Q3 2019 Oct 23, 2019	BUY	$1.93 - $4.21 $12,313 - $26,859	6,380 Added 7.88%	87,368 $205,000
Q2 2019 Aug 14, 2019	BUY	$2.05 - $4.32 $33,943 - $71,530	16,558 Added 25.7%	80,988 $350,000
Q1 2019 May 01, 2019	SELL	$1.79 - $3.12 $2,532 - $4,414	-1,415 Reduced 2.15%	64,430 $135,000
Q4 2018 Jan 31, 2019	BUY	$2.24 - $3.9 $46,264 - $80,550	20,654 Added 45.7%	65,845 $169,000
Q3 2018 Nov 07, 2018	BUY	$3.58 - $4.9 $358 - $490	100 Added 0.22%	45,191 $176,000
Q2 2018 Aug 06, 2018	SELL	$4.43 - $5.14 $8,638 - $10,023	-1,950 Reduced 4.15%	45,091 $215,000
Q1 2018 May 02, 2018	SELL	$4.65 - $5.9 $9,207 - $11,682	-1,980 Reduced 4.04%	47,041 $245,000
Q3 2017 Nov 06, 2017	BUY	$4.35 - $5.25 $213,241 - $257,360	49,021	49,021 $257,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $80.6M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Chimerix Inc Transaction History